{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:08:26Z","timestamp":1768982906638,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T00:00:00Z","timestamp":1322265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10103-011-1029-4","type":"journal-article","created":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T09:13:30Z","timestamp":1322212410000},"page":"1085-1090","source":"Crossref","is-referenced-by-count":21,"title":["Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach"],"prefix":"10.1007","volume":"27","author":[{"given":"M","family":"Gobbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Mustacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Biasotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,26]]},"reference":[{"issue":"1","key":"1029_CR1","first-page":"18","volume":"17","author":"M Fakih","year":"2010","unstructured":"Fakih M, Vincent M (2010) Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer. Curr Oncol 17(1):18\u201330","journal-title":"Curr Oncol"},{"key":"1029_CR2","doi-asserted-by":"crossref","unstructured":"Kuhnt T, Sandner A, Wendt T, Engenhart-Cabillic R, Lammering G, Flentje M, Grabenbauer G, Schreiber A, Pirnasch A, Dunst J. Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol. 2010 Apr 28","DOI":"10.1093\/annonc\/mdq216"},{"issue":"17","key":"1029_CR3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","volume":"359","author":"CS Karapetis","year":"2008","unstructured":"Karapetis CS, Khambata-Ford S, Jonker DJ, O\u2019Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757\u20131765","journal-title":"N Engl J Med"},{"issue":"2","key":"1029_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/COC.0b013e3181979093","volume":"33","author":"A Birnbaum","year":"2010","unstructured":"Birnbaum A, Dipetrillo T, Rathore R, Anderson E, Wanebo H, Puthwala Y, Joyce D, Safran H, Henderson D, Kennedy T, Ready N, Sio TT (2010) Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis. Am J Clin Oncol 33(2):144\u2013147","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"1029_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.007","volume":"90","author":"C Giro","year":"2009","unstructured":"Giro C, Berger B, B\u00f6lke E, Ciernik IF, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W (2009) High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother Oncol 90(2):166\u2013171","journal-title":"Radiother Oncol"},{"issue":"5","key":"1029_CR6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0001-7310(06)73407-X","volume":"97","author":"G Guhl","year":"2006","unstructured":"Guhl G, Gonz\u00e1lez-de Arriba A, Daud\u00e9n E (2006) Epidermal growth factor receptor inhibitors side effects. Actas Dermosifiliogr 97(5):296\u2013310","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"1029_CR7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jid.2009.336","volume":"130","author":"F Mascia","year":"2010","unstructured":"Mascia F, Cataisson C, Lee TC, Threadgill D, Mariani V, Amerio P, Chandrasekhara C, Souto-Adeva G, Girolomoni G, Yuspa SH, Pastore S (2010) EGFR regulates the expression of keratinocyte-derived granulocyte\/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol 130(3):682\u2013693","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1029_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000106075","volume":"20","author":"G Gencoglan","year":"2007","unstructured":"Gencoglan G, Ceylan C (2007) Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Skin Pharmacol Physiol 20(5):260\u2013262","journal-title":"Skin Pharmacol Physiol"},{"issue":"17","key":"1029_CR9","first-page":"945","volume":"151","author":"ML Tjin-A-ton","year":"2007","unstructured":"Tjin-A-ton ML, van Montfrans C, Koldenhof JJ, Sigurdsson V, Voest EE, Witteveen PO (2007) Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors. Ned Tijdschr Geneeskd 151(17):945\u2013952","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"1029_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D33426F09X","volume":"13","author":"J Bragg","year":"2007","unstructured":"Bragg J, Pomeranz MK (2007) Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab. Dermatol Online J 13(1):1","journal-title":"Dermatol Online J"},{"issue":"4","key":"1029_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","volume":"58","author":"N Heidary","year":"2008","unstructured":"Heidary N, Naik H, Burgin S (2008) Chemotherapeutic agents and the skin: an update. J Am Acad Dermatol 58(4):545\u2013570","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1029_CR12","first-page":"1","volume":"12","author":"ME Lacouture","year":"2007","unstructured":"Lacouture ME, Melosky BL (2007) Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective. Skin Therapy Lett 12(6):1\u20135","journal-title":"Skin Therapy Lett"},{"issue":"2","key":"1029_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","volume":"90","author":"DI Pryor","year":"2009","unstructured":"Pryor DI, Porceddu SV, Burmeister BH, Guminski A, Thomson DB, Shepherdson K, Poulsen M (2009) Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 90(2):172\u2013176","journal-title":"Radiother Oncol"},{"key":"1029_CR14","doi-asserted-by":"crossref","unstructured":"Tomkov\u00e1 H, Kohoutek M, Z\u00e1bojn\u00edkov\u00e1 M, Posp\u00ed\u0161kov\u00e1 M, Ost\u0159\u00ed\u017ekov\u00e1 L, Gharibyar M. Cetuximab-induced cutaneous toxicity. J Eur Acad Dermatol Venereol. 2009 Nov 18","DOI":"10.1111\/j.1468-3083.2009.03490.x"},{"issue":"4","key":"1029_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0029-1244831","volume":"135","author":"A Wollenberg","year":"2010","unstructured":"Wollenberg A, Kroth J, Hauschild A, Dirschka T (2010) Cutaneous side effects of EGFR inhibitors\u2014appearance and management. Dtsch Med Wochenschr 135(4):149\u2013154","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"1029_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1188\/08.CJON.283-290","volume":"12","author":"B Eaby","year":"2008","unstructured":"Eaby B, Culkin A, Lacouture ME (2008) An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors. Clin J Oncol Nurs 12(2):283\u2013290","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"1029_CR17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/annonc\/mdm400","volume":"19","author":"J Bernier","year":"2008","unstructured":"Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK (2008) Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19(1):142\u2013149","journal-title":"Ann Oncol"},{"issue":"7","key":"1029_CR18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00105-006-1256-y","volume":"58","author":"A Wollenberg","year":"2007","unstructured":"Wollenberg A, Moosmann N, Kroth J, Heinemann V, Klein E (2007) Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid. Hautarzt 58(7):615\u2013618","journal-title":"Hautarzt"},{"issue":"3","key":"1029_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2006.04.062","volume":"55","author":"E Ro\u00e9","year":"2006","unstructured":"Ro\u00e9 E, Garc\u00eda Muret MP, Marcuello E, Capdevila J, Pallar\u00e9s C, Alomar A (2006) Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J Am Acad Dermatol 55(3):429\u2013437","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1029_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1634\/theoncologist.2010-0298","volume":"16","author":"C Pinto","year":"2011","unstructured":"Pinto C, Barone CA, Girolomoni G, Russi EG, Merlano MC, Ferrari D, Maiello E (2011) Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 16(2):228\u2013238","journal-title":"Oncologist"},{"issue":"1","key":"1029_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/15569520802646552","volume":"28","author":"W Waris","year":"2009","unstructured":"Waris W, Naik S, Idrees I, Taha H, Camosino L, Mehrishi A, Saif MW (2009) Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer. Cutan Ocul Toxicol 28(1):41\u201344","journal-title":"Cutan Ocul Toxicol"},{"key":"1029_CR22","doi-asserted-by":"crossref","first-page":"19671","DOI":"10.1200\/jco.2010.28.15_suppl.e19671","volume":"28","author":"N Radovics","year":"2010","unstructured":"Radovics N, Kornek G, Thalhammer F et al (2010) Analysis of the effects of vitamin K1 cream on cetuximab-induced acne-like rash. J Clin Oncol 28:19671","journal-title":"J Clin Oncol"},{"issue":"3","key":"1029_CR23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1590\/S0365-05962011000300010","volume":"86","author":"F Santiago","year":"2011","unstructured":"Santiago F, Gon\u00e7alo M, Reis JP, Figueiredo A (2011) Adverse cutaneous reactions to epidermal growth factor receptor inhibitors: a study of 14 patients. An Bras Dermatol 86(3):483\u2013490","journal-title":"An Bras Dermatol"},{"issue":"5","key":"1029_CR24","first-page":"693","volume":"342","author":"TI Karu","year":"1995","unstructured":"Karu TI, Afanas\u2019eva NI (1995) Cytochrome c oxidase as the primary photoacceptor upon laser exposure of cultured cells to visible and near IR-range light. Dokl Akad Nauk 342(5):693\u2013695","journal-title":"Dokl Akad Nauk"},{"key":"1029_CR25","unstructured":"Lopez M, Gebbia N, Cascinu S, Marchetti P. Oncologia medica pratica 2010; 3a edizione; Societ\u00e0 Editrice Universo; 836\u20137; 1045; 1308; 1343\u20131347"},{"key":"1029_CR26","doi-asserted-by":"crossref","unstructured":"Balagula Y, Wu S, Su X, Lacouture ME. The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis. Ann Oncol. 2011 Mar 14.","DOI":"10.1093\/annonc\/mdr016"},{"issue":"3","key":"1029_CR27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1902\/jop.2010.100195","volume":"82","author":"G Aykol","year":"2011","unstructured":"Aykol G, Baser U, Maden I, Kazak Z, Onan U, Tanrikulu-Kucuk S, Ademoglu E, Issever H, Yalcin F (2011) The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment. J Periodontol 82(3):481\u2013488","journal-title":"J Periodontol"},{"issue":"2","key":"1029_CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/104454704774076163","volume":"22","author":"J Kujawa","year":"2004","unstructured":"Kujawa J, Zavodnik L, Zavodnik I, Buko V, Lapshyna A, Bryszewska M (2004) Effect of low-intensity (3.75-25 J\/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure. J Clin Laser Med Surg 22(2):111\u2013117","journal-title":"J Clin Laser Med Surg"},{"key":"1029_CR29","unstructured":"Katona E, Katona G, Dumitrescu M, Horvath J, Tanos E, Katona L. Membrane effects of the low level infrared laser irradiation, as seen in metabolically intact and impaired human blood cells. Romanian J. Biophys., Vol. 14, Nos. 1\u20134, P. 99\u2013108"},{"issue":"5","key":"1029_CR30","first-page":"357","volume":"49","author":"F Fahimipour","year":"2011","unstructured":"Fahimipour F, Nouruzian M, Anvari M, Tafti MA, Yazdi M, Khosravi M, Dehghannayeri Z, Sabounchi SS, Bayat M (2011) Effect of low-level laser therapy on experimental wounds of hard palate mucosa in mice. Indian J Exp Biol 49(5):357\u2013361","journal-title":"Indian J Exp Biol"},{"issue":"5","key":"1029_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/pho.2007.2218","volume":"26","author":"S Benedicenti","year":"2008","unstructured":"Benedicenti S, Pepe IM, Angiero F, Benedicenti A (2008) Intracellular ATP level increases in lymphocytes irradiated with infrared laser light of wavelength 904\u00a0nm. Photomed Laser Surg 26(5):451\u2013453","journal-title":"Photomed Laser Surg"},{"issue":"5","key":"1029_CR32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00004032-198905000-00015","volume":"56","author":"T Karu","year":"1989","unstructured":"Karu T (1989) Photobiology of low-power laser effects. Health Phys 56(5):691\u2013704","journal-title":"Health Phys"},{"issue":"1","key":"1029_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1011-1344(98)00219-X","volume":"49","author":"T Karu","year":"1999","unstructured":"Karu T (1999) Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B 49(1):1\u201317","journal-title":"J Photochem Photobiol B"},{"issue":"4","key":"1029_CR34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S","volume":"22","author":"N Grossman","year":"1998","unstructured":"Grossman N, Schneid N, Reuveni H, Halevy S, Lubart R (1998) 780\u00a0nm low power diode laser irradiation stimulates proliferation of keratinocyte cultures: involvement of reactive oxygen species. Lasers Surg Med 22(4):212\u2013218","journal-title":"Lasers Surg Med"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-011-1029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10103-011-1029-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-011-1029-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T23:40:06Z","timestamp":1639784406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10103-011-1029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,26]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s10103-011-1029-4","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,26]]}}}